Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Expression and significance of E-cadherin and β-catenins in pituitary adenoma.

Zhou K, Jin H, Luo Y.

Int J Surg Pathol. 2013 Aug;21(4):363-7. doi: 10.1177/1066896912471850. Epub 2013 Jan 24.

PMID:
23349466
2.
3.

Wnt4 is overexpressed in human pituitary adenomas and is associated with tumor invasion.

Li W, Zhang Y, Zhang M, Huang G, Zhang Q.

J Clin Neurosci. 2014 Jan;21(1):137-41. doi: 10.1016/j.jocn.2013.04.034. Epub 2013 Nov 5.

PMID:
24200887
4.

Combining Cadherin Expression with Molecular Markers Discriminates Invasiveness in Growth Hormone and Prolactin Pituitary Adenomas.

Chauvet N, Romanò N, Meunier AC, Galibert E, Fontanaud P, Mathieu MN, Osterstock G, Osterstock P, Baccino E, Rigau V, Loiseau H, Bouillot-Eimer S, Barlier A, Mollard P, Coutry N.

J Neuroendocrinol. 2016 Feb;28(2):12352. doi: 10.1111/jne.12352.

PMID:
26686489
5.

Role of E-cadherin, alpha-, beta-, and gamma-catenins, and p120 (cell adhesion molecules) in prolactinoma behavior.

Qian ZR, Li CC, Yamasaki H, Mizusawa N, Yoshimoto K, Yamada S, Tashiro T, Horiguchi H, Wakatsuki S, Hirokawa M, Sano T.

Mod Pathol. 2002 Dec;15(12):1357-65.

6.

Tumor-specific downregulation and methylation of the CDH13 (H-cadherin) and CDH1 (E-cadherin) genes correlate with aggressiveness of human pituitary adenomas.

Qian ZR, Sano T, Yoshimoto K, Asa SL, Yamada S, Mizusawa N, Kudo E.

Mod Pathol. 2007 Dec;20(12):1269-77. Epub 2007 Sep 14.

7.

Reduced expression of E-cadherin/catenin complex in hepatocellular carcinomas.

Zhai B, Yan HX, Liu SQ, Chen L, Wu MC, Wang HY.

World J Gastroenterol. 2008 Oct 7;14(37):5665-73.

8.

Down-regulation of E-cadherin and catenins in human pituitary growth hormone-producing adenomas.

Sano T, Rong QZ, Kagawa N, Yamada S.

Front Horm Res. 2004;32:127-32. Review.

PMID:
15281343
9.

Expression of E-cadherin and beta-catenin in the adenoma-carcinoma sequence of ampulla of Vater cancer.

Park S, Kim SW, Lee BL, Jung EJ, Kim WH.

Hepatogastroenterology. 2006 Jan-Feb;53(67):28-32.

PMID:
16506371
10.

Galectin-3 expression in pituitary adenomas as a marker of aggressive behavior.

Righi A, Morandi L, Leonardi E, Farnedi A, Marucci G, Sisto A, Frank G, Faustini-Fustini M, Zoli M, Mazzatenta D, Agati R, Foschini MP.

Hum Pathol. 2013 Nov;44(11):2400-9. doi: 10.1016/j.humpath.2013.05.020. Epub 2013 Sep 2.

PMID:
24007691
11.

Clinicopathological features of growth hormone-producing pituitary adenomas: difference among various types defined by cytokeratin distribution pattern including a transitional form.

Obari A, Sano T, Ohyama K, Kudo E, Qian ZR, Yoneda A, Rayhan N, Mustafizur Rahman M, Yamada S.

Endocr Pathol. 2008 Summer;19(2):82-91. doi: 10.1007/s12022-008-9029-z.

PMID:
18629656
12.

Upregulation of vimentin and aberrant expression of E-cadherin/beta-catenin complex in oral squamous cell carcinomas: correlation with the clinicopathological features and patient outcome.

Liu LK, Jiang XY, Zhou XX, Wang DM, Song XL, Jiang HB.

Mod Pathol. 2010 Feb;23(2):213-24. doi: 10.1038/modpathol.2009.160. Epub 2009 Nov 13.

13.

[Expression of E-cadherin catenin complex and invasiveness of pituitary adenoma].

Qu QY, Zhang QH, Wang XY.

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2006 Jun;41(6):433-6. Chinese.

PMID:
16927799
14.

Expression of epithelial cadherin and cavernous sinus invasion in human pituitary adenomas.

Kawamoto H, Mizoue T, Arita K, Tominaga A, Eguchi K, Kurisu K.

J Neurooncol. 1997 Sep;34(2):105-9.

PMID:
9210056
16.

Expression of Wnt4 in human pituitary adenomas regulates activation of the beta-catenin-independent pathway.

Miyakoshi T, Takei M, Kajiya H, Egashira N, Takekoshi S, Teramoto A, Osamura RY.

Endocr Pathol. 2008 Winter;19(4):261-73. doi: 10.1007/s12022-008-9048-9.

PMID:
19034702
17.

Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer.

Voutilainen KA, Anttila MA, Sillanpää SM, Ropponen KM, Saarikoski SV, Juhola MT, Kosma VM.

J Clin Pathol. 2006 May;59(5):460-7. Epub 2006 Feb 3.

18.

E-cadherin and β-catenin expression in well-differentiated and moderately-differentiated oral squamous cell carcinoma: relations with clinical variables.

Rosado P, Lequerica-Fernández P, Fernández S, Allonca E, Villallaín L, de Vicente JC.

Br J Oral Maxillofac Surg. 2013 Mar;51(2):149-56. doi: 10.1016/j.bjoms.2012.03.018. Epub 2012 Apr 21.

PMID:
22525043
19.

Reduced expression of molecules of the cadherin/catenin complex in the transition from colorectal adenoma to carcinoma.

Hao X, Palazzo JP, Ilyas M, Tomlinson I, Talbot IC.

Anticancer Res. 1997 May-Jun;17(3C):2241-7.

PMID:
9216695
20.

Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumors.

Shimazui T, Schalken JA, Giroldi LA, Jansen CF, Akaza H, Koiso K, Debruyne FM, Bringuier PP.

Cancer Res. 1996 Sep 15;56(18):4154-8.

Supplemental Content

Support Center